The performance of a hollow fibre artificial lung (,Capiox E,) was analysed by measurement of the 'parallel dead space , of the device under varying conditions in 21 patients. The efficiency with which carbon dioxide was exchanged was determined by the time available for equilibration between the blood and gas phases. When this equilibration coefficient was less than 12 seconds per litre of blood flow per litre of gas flow, there was a marked reduction in the efficiency of gas exchange. Under certain conditions, the 'counter-current' design of the device apparently permitted the clearance of carbon dioxide at a partial pressure greater than that which was found in the mixed venous blood. This anomalous behaviour may represent in vivo confirmation of the Haldane effect.
The performance of an artificial blood oxygenator is usually specified in terms of the transfer rates of the respiratory gases under particular operating conditions. This approach provides data which help to define the power of the device, but does not shed light on the determinants of oxygenator efficiency.
As it is possible that the efficiency of different oxygenators may vary considerably and that the performance of a particular device will vary under different conditions, we decided to study gas exchange in an artificial lung using the traditional physiological technique of three-compartment analysis. 1 Using this approach, the inefficiency of ventilation can be measured as 'parallel deadspace' and the inefficiency of perfusion can be measured as 'shunt'. In this paper we illustrate the use of deadspace measurement by describing some of the determinants of carbon dioxide transfer efficiency for a hollow fibre oxygenator.
MATERIALS AND METHODS
Twenty-one patients scheduled for routine openheart surgery -Nere studied. The patients ranged in age between 21 and 84 years (mean 68.7 years) and in weight between 53 and 86 kg (mean 69.5 kg). Seventeen underwent coronary artery bypass grafting and the remainder various valve replacement procedures. The design of the study was approved by our hospital ethics committee.
Perfusion was conducted in the normal manner for this institution using a Capiox 'E' hollow fibre oxygenator at an initial flowrate (Q) of 2.4 l.min -l.m -2. 100% oxygen was supplied to the oxygenator and fresh ('sweep') gas flow (Vt) and blood flow (Q) adjusted according to the usual practice of whichever perfusionist was involved. Moderate to deep hypothermia was used in all cases and anaesthesia during bypass was maintained using fentanyl and diazepam.
At random intervals, measurements of PC02 in the effiuent gas (PeC02, arterial (PaC02) and mixed venous (PVC02) blood were made. Blood phase measurements were performed on a Radiometer 'ABL4' blood gas analyser. These analyses were corrected to the arterial blood temperature at the time of sampling ('temperature corrected') using the built-in algorithms of the analyser.
Gas phase measurements were made on a combined infrared/paramagnetic monitor (Datex 'Cardiocap') sampling at a rate of 150 ml.min -1 and attached to the effiuent gas port of the oxygenator. Contamination of the gas sample with atmospheric gas was prevented by the addition of a small, open-ended reservoir distal to the sampling point. In those cases where nitrous oxide was administered before bypass, no measurements were made until the gas was undetectable in the effiuent.
Both analysers were calibrated periodically using standard solutions or gas mixtures and barometric pressure (Pb) was recorded using the ABL4. In total, 56 sets of readings were obtained from the 21 patients.
We calculated the parallel deadspace of the lung using the formula:
V dIVt = (PvC02 -Peco2)/PvC02 which in the case ofthe Capiox E is analogous to the Bohr equation 2 (Appendix 1) although in the figures we have plotted the value of:
1 -«PvC02 -P eco2)/PvC02) to represent that proportion of ventilation which is available for gas exchange.
We defined an equilibration coefficient (Appendix 1) which expressed the notional dwell time for the blood within the oxygenator per litre of Fresh Gas Flow and calculated this according to the formula:
(IIQ*V t))*60 Finally, C02 production in ml.min -1 (VC02) was estimated using the equation:
(P eco2/Pb) * V t * 1000 The data was curve-fitted using conventional linear least-squares regression. RESULTS 
Parallel dead space:
Parallel deadspace was affected by the overall V/Q ratio of the lung, fresh gas flow and equilibration coefficient.
The relationship between overall V/Q ratio of the lung and parallel deadspace. Values greater than unity represent clearance of CO 2 at partial pressures greater than those found in the venous blood. As the V/Q ratio was increased, so parallel deadspace tended to increase. The range of V/Q which we used varied between 0.12 and 1. 94. At low ratios « 0.06), the lung was able to clear C02 at a higher partial pressure than was found in the mixed venous blood. We termed this phenomenon 'super-efficiency'. Thereafter, as V/Q was increased, parallel deadspace increased, so that at ratios above 1, between 10 and 25% of the ventilating gas was typically wasted (Figure 1) .
Parallsl dcladspace and Fresh Cas Flow
Similarly, as fresh gas flow increased, so deadspace increased ( Figure 2 ). The oxygenator was usually 'super-efficient' at gas flows of up to 2 I.min -1 but above that flow rate there was a progressive increase in gas wastage.
The effect of equilibration coefficient is shown in Figure 3 . When this value was greater than 12 s.l-2 the lung was almost invariably 'super-efficient', but below this level there was a sudden and progressive increase in deadspace as the time available for equilibration was reduced. This value of equilibration coefficient corresponds to a lung operating at a blood flow of 2. 5 l.min -1 and a fresh gas flow of 2 l.min -1 and is therefore well within the normal operating range of the device. In those cases where PeC02 exceeded P v C02> the average PC02 difference was 1.9 mmHg. There was no apparent relationship between parallel deadspace and mixed venous temperature (R2 = 0.01) or blood flow (R2 = 0.00). Figure 4 expresses the relationship between effiuent and arterial CO 2 , As can be seen, effiuent CO 2 consistently overestimated arterial CO 2 and the best-fit curve differed significantly from the line of identity (P < 0.05). Nevertheless, the correlation between these variables was very close (R2 = 0.93).
Comparison with 'Temperature corrected' blood gas values:
In contrast, the venous CO 2 bore a much closer relationship to effiuent CO 2 and correlated to a similar degree (R2 = 0.92) ( Figure 5 ). The fit of this curve was not significantly different from the line of identity (P> 0.05).
These findings are explicable on the basis of the structure of the Capiox E which consists of approximately 30,000 microporous polypropylene fibres which carry the gas flow, while blood flow occurs outside the fibres and in the opposite direction ( Figure 6 ). This 'counter-current' blood:gas path implies that the incoming (venous) blood is first exposed to the effiuent gas whilst incoming gas is first exposed to the effiuent (arterial) blood. As the last blood 'seen' by the effiuent gas is venous, P eC02 more closely resembles the venous rather than arterial PC02. These relationships appeared to hold true over a wide range of C02 tensions and over a wide range of temperature. In the present series, the temperature-corrected arterial C02 tension varied between 11.0 and 37.2 mmHg and the arterial blood temperature between 17.6 and 40.1"C.
The effect of CO 2 production
There was an apparent relationship between CO 2 production and mixed venous blood temperatures (Figure 7) although the correlation was not particularly close (R2 = 0.63). A 10 degree C rise in venous temperature was associated with an approximate doubling in C02 production which at normothermia was approximately 80 ml.min-1 .m-2 • However, VC02 had no apparent effect on parallel deadspace (R 2 = 0.21).
DISCUSSION
Not unexpectedly, the efficiency of CO 2 transfer appeared to be determined principally by the time available for equilibration between the blood and gas phases within the device. It would also appear that there was a critical value of equilibration coefficient (-12 s.l-2) below which there was a sudden loss of efficiency and above which complete equilibration of CO 2 in the blood and gas phases had apparently occurred.
We were surprised by the finding that under some conditions, it was possible for the effiuent CO 2 to exceed the incoming venous PC02 ('superefficiency'). This can be explained in several ways. Firstly, it is possible that there was a systematic error in the temperature correction algorithm such that blood PC02 was consistently underestimated at low temperatures. This possibility can be discounted as instances of super-efficiency were found throughout the full temperature range.
Secondly, it is conceivable that a 'second gas' effect 3 was occurring at the venous end of the fibre. A priori, the blood:gas partial pressure differences in this kind of lung are such that the tension difference for carbon dioxide is greatest at the arterial end of the fibre whilst for oxygen it is greatest at the venous end. If the bulk of oxygen transfer also occurs at this end of the fibre, then the movement of oxygen in the absence of carbon dioxide exchange could be accompanied by elevation of effiuent PC02 above the level of the mixed venous blood.
The third mechanism which can be invoked is that of the 'Haldane effect'.4 As we have suggested, the kinetics of gas exchange in a counter-current hollow fibre are such that, at the venous end of the fibre, oxygen may be being transferred to the blood in the absence of CO 2 transfer in the opposite direction. Under these circumstances the affinity of haemoglobin for carbon dioxide will be reduced because oxyhaemoglobin is both a weaker buffer and less capable of carbamino formation than reduced haemoglobin. As a result, the partial pressure of C02 at the venous end of the fibre will rise above the true mixed venous value although the total content will remain unchanged. This effect has recently been demonstrated in apnoeic humans and is of comparable magnitude to the discrepancy which we have measured. 5 Further support for the view that the Haldane effect contributes significantly to the efficiency of carbon dioxide transfer comes from the observation that the capacity of the Capiox E for carbon dioxide transfer is reduced by 20-25% when the ventilating gas is nitrogen rather than oxygen (personal communication, Ohkawa M, Terumo Corporation).
Because of the correlation of etfluent CO 2 and arterial C02, it has been suggested that effiuent C02 analysis can be used as a guide to the arterial C02 tension for the purpose of acid-base management during bypass. Camerlengo and Dearing 6 found that for both bubble and membrane oxygenators, PeC02 accurately reflected PaC02 during all stages of bypass and this finding has been confirmed by others. 7 However, in a separate study, Riley8 concluded that P eco2 was only a fair predictor of PaC02 and that it was particularly likely to be in error when V C02 was high.
In the present study we were not able to confirm the correspondence of effiuent and arterial PC02, although we were able to demonstrate the similarity to mixed venous PC02. As we have mentioned, this finding is explicable given the 'counter-current' nature of the blood and gas channels.
By definition, absolute agreement between effiuent gas and blood CO 2 tensions can only occur when complete equilibration of blood and gas phases has had time to occur. Our measurements would suggest that in the case of the Capiox 'E' this equilibration time is of the order of 12 seconds per litre of blood per litre of gas. Because concordance of Pe CO2 with blood C02 may not occur if the time for equilibration is below the critical threshold, in principle we would not expect P eco2 to reflect PaC02 accurately at all stages of bypass. However, if the oxygenator is known to be operating at or above its time for complete equilibration, then effiuent PC02 will consitute an accurate reflection of blood Peo2·
In the case of the Capiox 'E', if the user wishes to use Peeo2 as an aid to pH management, it is probably reasonable to extrapolate from effiuent to arterial tension by subtracting the estimated A V Peo2 difference. If a 'pH stat'9 regime was being followed, no further correction of C02 tension would be required. If an 'Alpha stat' approach to pH management was required it would be necessary to use standard equations or nomograms to arrive at the Peo2 at 37"C.
We would predict that reversal of gas flow through the lung (so that blood and gas streams were co-current) would permit effiuent Peo2 to reflect arterial rather than venous PC02. Under these circumstances 'super-efficiency' could not occur as C02 and O 2 exchange would be proceeding in parallel along the length of the fibre and the parallel deadspace of the lung would increase.
We were not able to confirm the finding of Riley8 that Veo2 was an important determinant of the percentage disagreement between effiuent C02 and blood CO 2 . In effect, our measurement of deadspace corresponded to his percentage error plot and in our study deadspace was not significantly affected by Veo2 (R2 = 0.21). This is a little surprising in that C02 production was greatest at normothermia and at this time during bypass we would expect the dwell times for blood and gas to be shortest.
In summary, it is possible to describe the carbon dioxide exchanging efficiency of an artificial lung in terms of its 'parallel dead space '. When defined in this way, efficiency can be shown to be determined primarily by the time available for equilibration between the gas and blood phases and as a consequence, will also be affected by fresh gas flow and V/Q ratio. The decrease in efficiency which occurs as a result of reducing equilibration time is not a linear function of time; rather there is a fairly sudden onset of loss of efficiency which occurs within the normal operating range of the device. Finally, parallel deadspace appears to be largely independent of carbon dioxide production.
Fortuitously, the counter-current design of the Capiox 'E' lung is such that we have possibly confirmed the recent in vivo demonstration of the Haldane effect in the human lung. 5 
